Close
Achema middle east

Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Synthetic Drugs: A Growing Crisis or Signs of Improvement?

The landscape of drug usage has undergone significant changes...

Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation

Eli Lilly, the US pharma giant, has become the...

400 Global Regulatory Manufacturing Approvals for Samsung Biologics

Samsung Biologics announced on November 26, 2025, that it has gone...
- Advertisement -

Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Jim Kennamer as Senior Vice President and Site Head of North Carolina.

With over 30 years’ experience in the Pharmaceutical industry, Jim has held various positions with increasing levels of responsibilities at Boehringer Mannheim Biochemical, Roche Molecular Biochemicals, Diosynth, Strategene, and Talecris Biotherapeutics/Grifols Therapeutics. For the past six years he has been the Vice President of Global Manufacturing Operations for Immucor in Norcross Georgia.

Jim has deep experience with manufacturing operations and processes, particularly in process improvements. He has driven regulatory compliance and audit readiness for multiple regulatory agencies, established complex supply agreements, and has driven LEAN and right first-time operations throughout his organizations. Jim previously sat on the North Carolina State University Biotechnology Training and Education Center (BTEC) Advisory Board.

Jim has a Bachelor of Science Degree in Biochemistry from Oklahoma State University in Stillwater, Oklahoma and a Doctor of Philosophy, Biochemistry also from Oklahoma State University.

Latest stories

Related stories

Synthetic Drugs: A Growing Crisis or Signs of Improvement?

The landscape of drug usage has undergone significant changes...

Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation

Eli Lilly, the US pharma giant, has become the...

400 Global Regulatory Manufacturing Approvals for Samsung Biologics

Samsung Biologics announced on November 26, 2025, that it has gone...

Clinical Trial Services and the Role of a European CRO

Conducting a clinical trial today requires coordinated procedures, standardized...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »